Drug Trial Radar · NCT04007991
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
Last checked: Nov 19, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
153
Actual
Start
Jun 28, 2019
Primary completion
Sep 23, 2021
Study completion Sep 23, 2021
Sponsor
- Lead sponsor
- Emalex Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 5, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets
Conditions
- Tourette Syndrome
Interventions
EcopipamDrug
Ecopipam HCI tablets administered PO to establish 2 mg/kg/day
PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) at Week 12Time frame: Baseline, Week 12
Locations
70 sites in 5 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
Phoenix Children's Hospital
Phoenix, Arizona
Advanced Research Center Inc.
Anaheim, California
UCLA
Los Angeles, California
PCSD-Feighner Research
San Diego, California
Syrentis Clinical Research
Santa Ana, California
Yale School of Medicine
New Haven, Connecticut
Sarkis Clinical Trials
Gainesville, Florida
Northwest Florida Clinical Research Group, LLC
Gulf Breeze, Florida
Research in Miami Inc.
Hialeah, Florida
University of Miami
Miami, Florida
MedBio Trials
North Miami, Florida
APG Research LLC
Orlando, Florida
University of South Florida
St. Petersburg, Florida
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida
Pediatric Neurology, PA
Winter Park, Florida
Rare Disease Research, LLC
Atlanta, Georgia
Meridian Clinical Research
Savannah, Georgia
Rush University Medical Center
Chicago, Illinois
The University of Chicago Hospitals
Chicago, Illinois
AMR - Baber Research Inc.
Naperville, Illinois
Psychiatric Associates
Overland Park, Kansas
Massachusetts General Hospital
Boston, Massachusetts
Michigan Clinical Research Institute PC
Ann Arbor, Michigan
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan
Helen DeVos Children's Hospital / Spectrum Health Medical Group
Wyoming, Michigan
St. Charles Psychiatric Associates dba Midwest Research Group
Saint Charles, Missouri
Movement Disorders Center
St Louis, Missouri
Alivation Research, LLC
Lincoln, Nebraska
Center for Psychiatry and Behavioral Medicine Inc.
Las Vegas, Nevada
The NeuroCognitive Institute
Mount Arlington, New Jersey
Clinical Research Center of NJ
Voorhees Township, New Jersey
New York Neurology Associates P.C
New York, New York
Hapworth Research Inc.
New York, New York
Mount Sinai School of Medicine
New York, New York
Mood Disorders Consulting Medicine PLLC
New York, New York
Finger Lakes Clinical Research
Rochester, New York
Quest Therapeutics of Avon Lake
Avon Lake, Ohio
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.